Seronegative spondyloarthropathy-associated inflammatory bowel disease.
Wang CR, Tsai HW.
World J Gastroenterol. 2023 Jan 21;29(3):450-468. doi: 10.3748/wjg.v29.i3.450.
Secukinumab in patients with psoriatic arthritis and axial manifestations: results from the double-blind, randomised, phase 3 MAXIMISE trial.
Baraliakos X, Gossec L, Pournara E, Jeka S, Mera-Varela A, D'Angelo S, Schulz B, Rissler M, Nagar K, Perella C, Coates LC.
Ann Rheum Dis. 2021 May;80(5):582-590. doi: 10.1136/annrheumdis-2020-218808. Epub 2020 Dec 17.
Predominant ligament-centric soft-tissue involvement differentiates axial psoriatic arthritis from ankylosing spondylitis.
McGonagle D, David P, Macleod T, Watad A.
Nat Rev Rheumatol. 2023 Dec;19(12):818-827. doi: 10.1038/s41584-023-01038-9. Epub 2023 Nov 2.
Targeted depletion of TRBV9+ T cells as immunotherapy in a patient with ankylosing spondylitis.
Britanova OV, Lupyr KR, Staroverov DB, Shagina IA, Aleksandrov AA, Ustyugov YY, Somov DV, Klimenko A, Shostak NA, Zvyagin IV, Stepanov AV, Merzlyak EM, Davydov AN, Izraelson M, Egorov ES, Bogdanova EA, Vladimirova AK, Iakovlev PA, Fedorenko DA, Ivanov RA, Skvortsova VI, Lukyanov S, Chudakov DM.
Nat Med. 2023 Nov;29(11):2731-2736. doi: 10.1038/s41591-023-02613-z. Epub 2023 Oct 23.
Spondyloarthritides.
Baraliakos X, Braun J.
Best Pract Res Clin Rheumatol. 2011 Dec;25(6):825-42. doi: 10.1016/j.berh.2011.11.006.
Seronegative spondyloarthritides.
Calin A.
Med Clin North Am. 1986 Mar;70(2):323-36.
Guselkumab provides durable improvement across psoriatic arthritis disease domains: post hoc analysis of a phase 3, randomised, double-blind, placebo-controlled study.
Coates LC, Gossec L, Zimmermann M, Shawi M, Rampakakis E, Shiff NJ, Kollmeier AP, Xu XL, Nash P, Mease PJ, Helliwell PS.
RMD Open. 2024 Mar 26;10(1):e003977. doi: 10.1136/rmdopen-2023-003977.
Psoriatic arthritis.
Gladman DD.
Rheum Dis Clin North Am. 1998 Nov;24(4):829-44, x. doi: 10.1016/s0889-857x(05)70044-2.
[Psoriatic rheumatism].
Bardin T.
Rev Prat. 2004 Jan 15;54(1):60-8.
Time to lift the moratorium on IL-23 inhibitors for axial psoriatic arthritis.
Tonutti A, Abacar K, Macleod T, Selmi C, McGonagle D.
Lancet Rheumatol. 2026 Feb;8(2):e144-e156. doi: 10.1016/S2665-9913(25)00287-5. Epub 2025 Nov 27.
